RxDoctor Payments Data

Kevin Witt, MD

Family Medicine · St Petersburg, FLNPI 1023076510

Payments from drug & device makers

$282in general payments, 2019–2025

Across 12 payments — averaging $23.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$90
  • Novo Nordisk$70
  • AstraZeneca$40
  • Amarin Pharma, Inc.$16
  • GSK$14
  • Antares Pharma, Inc.$14
  • plus $37 from 3 others

What the payments were for

  • Food & beverage$19168%
  • Education$9032%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$282 in reported general payments places this provider in the 40th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$46,375
Medicare patients
234
Services billed
502

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban122$131,388
TrulicityDulaglutide57$72,395
OzempicSemaglutide72$67,419
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$36,390
XareltoRivaroxaban22$30,542
JanuviaSitagliptin Phosphate18$18,326
FarxigaDapagliflozin Propanediol15$15,300
MyrbetriqMirabegron18$13,383
MounjaroTirzepatide13$13,273
SymbicortBudesonide/Formoterol Fumarate25$7,285
Breo ElliptaFluticasone/Vilanterol18$7,252
Lantus SolostarInsulin Glargine,hum.Rec.Anlog36$5,787
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen146$5,282
Atorvastatin Calcium529$4,705
Levothyroxine Sodium410$3,983

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$90$132,817161 claims
Lilly USA, LLCTrulicity, Mounjaro$11$85,66870 claims
Novo NordiskOzempic$70$67,41972 claims
GSKTrelegy Ellipta, Breo Ellipta$14$43,64261 claims
Johnson & JohnsonXarelto$13$30,54222 claims
AstraZenecaFarxiga, Symbicort$40$22,58640 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 7,282 family medicine providers in Florida.

Other family medicine in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →